Imattix Biomedicine announced that research results related to its PRAME tumor antigen pipeline will be presented at the 2026 European Society of Medical Oncology Conference.

Zhitongcaijing · 1d ago
Imattix Biomedicine announced that research results related to its PRAME tumor antigen pipeline will be presented at the 2026 European Society of Medical Oncology Conference.